References
- Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002; 2:850 - 61; http://dx.doi.org/10.1038/nrc928; PMID: 12415255
- Hayakawa Y, Sato-Matsushita M, Takeda K, Iwakura Y, Tahara H, Irimura T. Early activation and interferon-γ production of tumor-infiltrating mature CD27 high natural killer cells. Cancer Sci 2011; 102:1967 - 71; http://dx.doi.org/10.1111/j.1349-7006.2011.02042.x; PMID: 21781225
- Huntington ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, Degli-Esposti MA, Smyth MJ, Tarlinton DM, Nutt SL. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol 2007; 178:4764 - 70; PMID: 17404256
- Gordon SM, Chaix J, Rupp LJ, Wu J, Madera S, Sun JC, Lindsten T, Reiner SL. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012; 36:55 - 67; http://dx.doi.org/10.1016/j.immuni.2011.11.016; PMID: 22261438
- Malaisé M, Rovira J, Renner P, Eggenhofer E, Sabet-Baktach M, Lantow M, Lang SA, Koehl GE, Farkas SA, Loss M, et al. KLRG1+ NK Cells Protect T-bet-Deficient Mice from Pulmonary Metastatic Colorectal Carcinoma. J Immunol 2014; 192:1954 - 61; http://dx.doi.org/10.4049/jimmunol.1300876; PMID: 24415778
- Werneck MB, Lugo-Villarino G, Hwang ES, Cantor H, Glimcher LH. T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J Immunol 2008; 180:8004 - 10; PMID: 18523263
- Peng SL, Townsend MJ, Hecht JL, White IA, Glimcher LH. T-bet regulates metastasis rate in a murine model of primary prostate cancer. Cancer Res 2004; 64:452 - 5; http://dx.doi.org/10.1158/0008-5472.CAN-03-3401; PMID: 14744755
- Kroemer A, Xiao X, Degauque N, Edtinger K, Wei H, Demirci G, Li XC. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008; 180:7818 - 26; PMID: 18523245
- Meazza R, Azzarone B, Orengo AM, Ferrini S. Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy. J Biomed Biotechnol 2011; 2011:861920; http://dx.doi.org/10.1155/2011/861920; PMID: 21716670
- Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009; 9:302 - 12; http://dx.doi.org/10.1038/nrc2627; PMID: 19308069